Guangdong Sanggu Medical Robot Co., Ltd. is located in Danzao Town, Nanhai District, Foshan City. It began R&D on intravenous drug compounding robots in 2010 and is one of the earliest companies in China engaged in the R&D, production, sales, and after-sales service of hospital intravenous drug compounding robots.
Sanggu Medical is a high-tech enterprise invested in by listed companies, state-owned capital, and others. In 2020, it was the sole recipient of the "Guangdong Provincial Intravenous Drug Compounding Robot Engineering Technology Research Center" designation awarded by the Guangdong Provincial Department of Science and Technology.
Sanggu Medical owns a total of 79 intellectual property rights, including invention patents, utility model patents, design patents, and copyrights, among which 38 are invention patents. The company's self-developed fully automatic intravenous drug compounding robot has significant advantages such as safety, high efficiency, precision, stability, and high cost-effectiveness. It has been recognized and used by many well-known domestic hospitals, including Peking University Cancer Hospital, the Second Xiangya Hospital of Central South University, and Southwest Hospital of Army Medical University. It has also been exported to King Chulalongkorn Memorial Hospital in Thailand, making it the first to achieve product overseas expansion.
WeChat QR code
